Advice on Recognizing the Complexity of Early NSCLC Advice on Recognizing the Complexity of Early NSCLC
Jamie Chaft, MD, shares insights on personalized approaches, considerations for induction therapy, and the importance of staying informed.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 10, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news
Four Crucial Tips for Early-Career Clinicians Managing Early-Stage Non-Small Cell Lung Cancer Four Crucial Tips for Early-Career Clinicians Managing Early-Stage Non-Small Cell Lung Cancer
Narjust Florez, MD, provides four essential pieces of advice for early-career clinicians when treating early-stage non –small cell lung cancer.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 10, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news
3 health care stocks off to strong starts in 2024
Up 2% five trading days into the new year, global health care stocks have already matched their return for all of 2023. It’s very early, but the sector has outpaced all other 10 economic groups since the ball dropped in Times Square. Following a year that was dominated by technology, could 2024 be…#timessquare #glp1 #amgeninc #nasdaq100 #fda #amgen #nsclc #lumakras #jeffries #amgn (Source: Reuters: Health)
Source: Reuters: Health - January 10, 2024 Category: Consumer Health News Source Type: news
Considering Quality of Life as a Measure in Early NSCLC Considering Quality of Life as a Measure in Early NSCLC
Jared Weiss, MD, examines the need for a variety of measures to understand the total picture of treating early-stage NSCLC.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 9, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news
Reducing Disparities in the Treatment of Early NSCLC Reducing Disparities in the Treatment of Early NSCLC
Jared Weiss, MD, considers the many causes and forms of treatment disparities in early non-small cell lung cancer.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 9, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news
Experiencing the Evolution of Early NSCLC Treatment Experiencing the Evolution of Early NSCLC Treatment
Jared Weiss, MD, reflects on his first encounter in training with a patient with early NSCLC and how the treatment landscape has rapidly changed since then.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 8, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news
Early NSCLC: Three Forms That Contribute to Failure to Diagnose Early NSCLC: Three Forms That Contribute to Failure to Diagnose
Jared Weiss, MD, reflects on the profound impact of patient experiences in which early diagnosis of NSCLC was missed.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 8, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news
Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung Cancer Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung Cancer
Narjust Florez, MD, reflects on the significant changes in the treatment landscape of early-stage non-small cell lung cancer in recent years.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
NATICK, Mass., Jan. 2, 2024 -- (Healthcare Sales & Marketing Network) -- Allorion Therapeutics ("Allorion"), a US and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune ... Biopharmaceuticals, Oncology, Licensing Allorion Therapeutics, EGFR, non-small cell lung cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 2, 2024 Category: Pharmaceuticals Source Type: news
Amgen Provides Regulatory Update on Status of Lumakras(R) (Sotorasib)
FDA Has Issued New Postmarketing Requirement
LUMAKRAS Dosing Confirmed at 960 mg Once-Daily for Patients With KRAS G12C-Mutated NSCLC Under Accelerated Approval
THOUSAND OAKS, Calif., Dec. 26, 2023 -- (Healthcare Sales & Marketing Network) -- Amgen ... Biopharmaceuticals, Oncology, FDA Amgen, LUMAKRAS, sotorasib, non-small cell lung cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 26, 2023 Category: Pharmaceuticals Source Type: news
Patritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Submission based on HERTHENA-Lung01 results showing patritumab deruxtecan demonstrated clinically meaningful and durable responses in patients with advanced EGFR-mutated non-small cell lung cancer previously treated with two or more systemic... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 22, 2023 Category: Drugs & Pharmacology Source Type: news
Study Looks at Survival in Metastatic NSCLC Treated With Immunotherapy
WEDNESDAY, Dec. 13, 2023 -- For patients with metastatic non-small cell lung cancer (NSCLC) receiving immunotherapy, outcomes are similar across racial and ethnic groups, but ECOG performance status (PS) is associated with survival, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 13, 2023 Category: Pharmaceuticals Source Type: news
Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug
(MedPage Today) -- It may be possible to detect ovarian cancer years in advance of actual symptom onset based on the molecular and genetic analysis of cells taken from routine Pap tests. (Science Translational Medicine)
A six-patient clinical... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 7, 2023 Category: Hematology Source Type: news
A Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggests
Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC). And in an early parallel study in humans, combining immunotherapy with dupilumab—an... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 6, 2023 Category: Pharmaceuticals Tags: SVY Source Type: news
Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations
(MedPage Today) -- Osimertinib (Tagrisso) demonstrated promising clinical activity as first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) with uncommon EGFR mutations, the nonrandomized UNICORN trial from Japan... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 22, 2023 Category: Hematology Source Type: news
